French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vac ...
GlaxoSmithKline (GSK) Pharmaceuticals clocked 6 per cent growth in revenue for the January to March quarter at Rs 807 crore as compared to the same period of the previous fiscal. ...